Explore how JWA and XRCC1 biomarkers are transforming personalized medicine for gastric cancer patients through DNA repair mechanisms and predictive diagnostics.
Exploring the paradigm shift in treating stage IV gastric cancer through surgical approaches combined with systemic therapy.